It downregulates the levels of HIF-1α, GLUT-1, and VEGF in pancreatic carcinoma [58] and inhibits the level of MMP-2, MMP-9, uPA, and VEGF in TRAMP mouse by downregulating IGF-I/IGFBP-3 signaling [59]. The gene discussed is SLC2A1; the disease is exocrine pancreatic carcinoma.